دورية أكاديمية
أعرض في EDS

Role of Diagnostic Nerve Blocks in the Goal-Oriented Treatment of Spasticity with Botulinum Toxin Type A: A Case-Control Study.

التفاصيل البيبلوغرافية
العنوان: Role of Diagnostic Nerve Blocks in the Goal-Oriented Treatment of Spasticity with Botulinum Toxin Type A: A Case-Control Study.
المؤلفون: Filippetti M; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy., Tamburin S; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy., Di Censo R; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy., Adamo M; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy., Manera E; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy., Ingrà J; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy., Mantovani E; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy., Facciorusso S; Spasticity and Movement Disorders 'ReSTaRt' Unit, Physical Medicine and Rehabilitation Section, Policlinico Riuniti Hospital, University of Foggia, 71122 Foggia, Italy., Battaglia M; Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont 'A. Avogadro', 28100 Novara, Italy., Baricich A; Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont 'A. Avogadro', 28100 Novara, Italy., Santamato A; Spasticity and Movement Disorders 'ReSTaRt' Unit, Physical Medicine and Rehabilitation Section, Policlinico Riuniti Hospital, University of Foggia, 71122 Foggia, Italy., Smania N; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy., Picelli A; Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy.; Canadian Advances in Neuro-Orthopedics for Spasticity Consortium (CANOSC), Kingston, ON K7K 1Z6, Canada.
المصدر: Toxins [Toxins (Basel)] 2024 Jun 03; Vol. 16 (6). Date of Electronic Publication: 2024 Jun 03.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101530765 Publication Model: Electronic Cited Medium: Internet ISSN: 2072-6651 (Electronic) Linking ISSN: 20726651 NLM ISO Abbreviation: Toxins (Basel) Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel : MDPI
مواضيع طبية MeSH: Nerve Block* , Botulinum Toxins, Type A*/therapeutic use , Muscle Spasticity*/diagnosis , Muscle Spasticity*/therapy , Neurological Rehabilitation*/methods, Humans ; Male ; Adult ; Middle Aged ; Aged ; Case-Control Studies ; Goals
مستخلص: The goal-setting process is pivotal in managing patients with disabling spasticity. This case-control study assessed the role of diagnostic nerve blocks in guiding the goal-setting process within goal-targeted treatment of spasticity with botulinum neurotoxin-A. In this case-control study, patients with disabling spasticity underwent either a goal-setting process based on the patient's needs and clinical evaluation (control group) or additional diagnostic nerve block procedures (case group). All enrolled patients underwent a focal treatment with botulinum neurotoxin-A injection and a 1-month follow-up evaluation during which goal achievement was quantified using the goal attainment scaling-light score system. Data showed a higher goal achievement rate in the case group (70%) than in the control group (40%). In conclusion, diagnostic nerve blocks may help guide the goal-setting process within goal-targeted treatment of spasticity with botulinum neurotoxin-A towards more realistic and achievable goals, thereby improving the outcomes of botulinum neurotoxin-A injection. Future studies should better explore the role of diagnostic nerve blocks to further personalize botulinum neurotoxin-A according to individual patients' preferences and requirements.
References: Eur J Phys Rehabil Med. 2018 Jun;54(3):469-485. (PMID: 28264546)
J Rehabil Med. 2022 Jan 03;54:jrm00241. (PMID: 34608495)
Neurology. 2016 May 10;86(19):1818-26. (PMID: 27164716)
Eur J Hosp Pharm. 2021 Mar;28(2):106-108. (PMID: 33608439)
Arch Phys Med Rehabil. 2023 Mar;104(3):372-379. (PMID: 36030892)
Ann Phys Rehabil Med. 2019 Jul;62(4):252-264. (PMID: 31202956)
Australas J Ultrasound Med. 2023 Jun 28;26(4):236-242. (PMID: 38098618)
Int J Sports Phys Ther. 2012 Jun;7(3):279-87. (PMID: 22666642)
J Rehabil Med. 2005 Mar;37(2):75-82. (PMID: 15788341)
J Rehabil Med. 2022 Mar 29;54:jrm00275. (PMID: 35266004)
J Neurol. 2017 Jan;264(1):112-120. (PMID: 27787630)
Curr Opin Neurol. 2022 Dec 1;35(6):728-740. (PMID: 36226708)
Phys Ther. 2010 Feb;90(2):196-208. (PMID: 20022995)
PM R. 2017 Feb;9(2):136-148. (PMID: 27346090)
Am J Phys Med Rehabil. 2015 Sep;94(9):740-7. (PMID: 26135374)
Stroke. 2012 Nov;43(11):3132-6. (PMID: 22984012)
Physiother Can. 2017;69(2):113-119. (PMID: 28539691)
Mult Scler. 2016 Oct;22(11):1386-1396. (PMID: 27207462)
Am J Phys Med Rehabil. 2016 Sep;95(9):698-708. (PMID: 26945217)
J Rehabil Med. 2017 Jun 28;49(6):461-468. (PMID: 28451697)
Toxins (Basel). 2023 Mar 31;15(4):. (PMID: 37104194)
PM R. 2017 Oct;9(10):960-968. (PMID: 28286053)
Health Technol Assess. 2010 May;14(26):1-113, iii-iv. (PMID: 20515600)
Eur J Phys Rehabil Med. 2018 Jun;54(3):486-498. (PMID: 28382814)
J Rehabil Med. 2021 Jan 1;53(1):jrm00133. (PMID: 33206198)
BMJ Neurol Open. 2020 Jun 21;2(1):e000015. (PMID: 33681772)
Mult Scler. 2004 Oct;10(5):589-95. (PMID: 15471378)
J Rehabil Med. 2020 Jun 12;52(6):jrm00069. (PMID: 32432331)
Patient. 2016 Dec;9(6):537-546. (PMID: 27154536)
Gait Posture. 2011 Feb;33(2):185-9. (PMID: 21131203)
Neurorehabil Neural Repair. 2009 Jun;23(5):435-40. (PMID: 19261767)
Clin Rehabil. 2002 Aug;16(5):515-22. (PMID: 12194622)
Toxins (Basel). 2023 Nov 29;15(12):. (PMID: 38133180)
COPD. 2005 Mar;2(1):125-9. (PMID: 17136972)
Disabil Rehabil. 2019 Aug;41(16):1925-1930. (PMID: 29558228)
Toxins (Basel). 2022 Aug 24;14(9):. (PMID: 36136520)
Int J Rehabil Res. 2012 Sep;35(3):227-33. (PMID: 22555318)
Mult Scler Relat Disord. 2022 Dec;68:104376. (PMID: 36544321)
Eur J Pain. 2004 Aug;8(4):283-91. (PMID: 15207508)
Arch Phys Med Rehabil. 2023 Sep;104(9):1539-1548. (PMID: 36740138)
Toxins (Basel). 2016 Mar 04;8(3):. (PMID: 26959061)
فهرسة مساهمة: Keywords: botulinum neurotoxin-A; diagnostic nerve block; goal-setting process; neurorehabilitation; personalized treatment; spasticity
المشرفين على المادة: EC 3.4.24.69 (Botulinum Toxins, Type A)
تواريخ الأحداث: Date Created: 20240626 Date Completed: 20240627 Latest Revision: 20240629
رمز التحديث: 20240629
مُعرف محوري في PubMed: PMC11209555
DOI: 10.3390/toxins16060258
PMID: 38922151
قاعدة البيانات: MEDLINE
الوصف
تدمد:2072-6651
DOI:10.3390/toxins16060258